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Abstract Cell motility entails the extension of cytoplasmic
processes, termed lamellipodia and filopodia. Extension is driven
by actin polymerisation at the tips of these processes via
molecular complexes that remain to be characterised. We show
here that a green fluorescent protein (GFP) fusion of the
Wiskott^Aldrich syndrome protein family member Scar1/
WAVE1 is specifically recruited to the tips of lamellipodia in
living B16F1 melanoma cells. Scar1^GFP was recruited only to
protruding lamellipodia and was absent from filopodia. The
localisation of Scar was facilitated by the finding that the
formerly described inhibition of lamellipodia formation by
ectopical expression of Scar, could be overcome by the treatment
of cells with aluminium fluoride. These findings show that Scar is
strategically located at sites of actin polymerisation specifically
engaged in the protrusion of lamellipodia. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Cell motility is initiated via the controlled nucleation and
polymerisation of actin ¢laments to produce sheet- or ¢nger-
like projections, termed lamellipodia and ¢lopodia (reviewed
in [1]) that are induced, respectively, via activation of the Rho
family members, Rac and Cdc42 (reviewed in [2]). The alter-
native chains of molecular events linking external signals to
actin polymerisation have still to be de¢ned, but are thought
to terminate with the activation of the Arp2/3 complex, a
ubiquitous nucleator of actin ¢lament assembly (reviewed in
[3,4]). Current evidence places members of the Wiskott^Al-
drich syndrome protein family, WASP, N-WASP and Scar/
WAVE (subsequently referred to as Scar) directly upstream of
Arp2/3 in the signalling pathway [3]. Thus, the homologous
C-terminal regions of these proteins have been shown to acti-
vate Arp2/3-induced actin polymerisation in vitro (reviewed in
[5]) and studies of living cells have demonstrated the require-
ment of WASP/N-WASP for ¢lopodia formation [6,7] and
Scar for lamellipodia formation [8,9]. A conspicuous di¡er-
ence between WASP/N-WASP and three isoforms of Scar is
the presence in the former of a CRIB domain, which mediates
the direct binding of Cdc42, and renders WASP/N-WASP
competent in the activation of the Arp2/3 complex [10]. Scar
does not bind Rac, but recent studies suggest that the insulin
receptor substrate IRSp53 acts as the binding intermediate
between Scar and Rac [11] in the activation pathway. Other
studies have identi¢ed the Abl tyrosine kinase and cAMP-de-
pendent protein kinase as WAVE binding partners, thereby
implicating WAVE in the recruitment of these kinases to sites
of actin cytoskeleton remodelling [12].
The mechanism of protrusion of cytoplasmic processes has
been likened to the intracellular propulsion of pathogens that
hijack the motile machinery of cells to spread their infection
(reviewed in [13,14]). Among these pathogens, both Shigella
bacteria and Vaccinia virus recruit N-WASP to their surface
for the purpose of nucleating the formation of the actin comet
tail that drives them through cytoplasm. N-WASP is con¢ned
to the surface of the bacterium at the head of the tail and, via
signaling intermediates that are currently being unveiled [14],
recruits and activates the Arp2/3 complex. Subsequent to actin
¢lament nucleation, the Arp2/3 complex is presumed to dis-
sociate from N-WASP, and appears to take up a cross-linking
role in the comet tail (reviewed in [13]). To what extent this
scenario mimics lamellipodia and ¢lopodia formation has yet
to be established. What has been shown is that Arp2/3 local-
ises across the breadth of the lamellipodium [15,16] and that
co-partners in actin ¢lament dynamics found at the head of
comet tails, including VASP and pro¢lin [17,18] are recruited
to lamellipodia and ¢lopodia tips. Signi¢cantly, Arp2/3 is ap-
parently absent from ¢lopodia [16].
In line with the requirement of, respectively, N-WASP and
Scar for ¢lopodia and lamellipodia formation, we would ex-
pect a di¡erential localisation of these WASP family members
in ru¥ing membranes of motile cells. Speci¢cally, if these
proteins are engaged in actin nucleating activity, they would
be expected to localise to the very tips of the membrane pro-
cesses, where actin incorporation occurs [19]. Indeed, Scar has
been localised by antibody labelling to ru¥ing membranes [8]
as well as to focal adhesions [12]. However, the precise local-
isation of Scar in lamellipodia as well as the dynamics of its
recruitment were not established. We here report the local-
isation of Scar1 in living cells and show that it is speci¢cally
recruited to the tips of lamellipodia but not of ¢lopodia. The
determination of Scar localisation was facilitated by the use of
conditions to activate lamellipodia formation that overcome
the detrimental e¡ects of the overexpression of Scar noted in
former studies [8,9].
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2. Materials and methods
2.1. EGFP^Scar1 constructs
Full length human Scar1 in a pSPORT1 vector was a gift from T.
Nagase (Kazusa DNA Research Institute). With this as a template,
Scar1^EGFP was generated by polymerase chain reaction (PCR), us-
ing a sense primer (GAG AGA ATT CGC CAC CAT GCC GCT
AGT GAA AAG) to introduce an EcoRI site and an antisense primer
(GAG AGA GGA TCC CTC CAA CCA ATC TAC TTC) to intro-
duce a BamHI site, followed by removal of the stop codon. The PCR
product was cloned in frame into the EcoRI/BamHI sites of an
EGFP-N3 vector (Clontech, Germany). Scar^WA was ampli¢ed using
C ATT CGA GAA TTC TCG CCT GTC ATG GTT ACA GC as a
sense primer and GG CCG AAT TCT CTG CAG GAA TCC TAA
CTC CAA CC as an antisense primer. The ampli¢ed fragments were
cloned in frame into the EcoRI site of an EGFP-N1 vector and the
correct sequences of the constructs con¢rmed.
2.2. Immunoprecipitation and Western blotting
Immunoprecipitation of Scar1^GFP using a polyclonal green £uo-
rescent protein (GFP) antibody was performed as described earlier
[20] with minor modi¢cations in the bu¡er (20 mM imidazole, 120
mM NaCl, 2 mM MgCl2, 5% (v/v) glycerol, 0.5% (v/v) Triton X-100,
1 mM phenylmethylsulfonyl £uoride, 1 mM NaN3, pH 7.0). Analyt-
ical sodium dodecyl sulphate^gel electrophoresis on 8^22% gradient
polyacrylamide mini-slab gels and Western blotting onto nitrocellu-
lose (Pall-Gelman, Austria) was performed as described elsewhere
[21]. Transferred proteins were visualised using a monoclonal anti-
body to GFP, horseradish peroxidase-coupled secondary antibodies
and the enhanced chemiluminescence detection system (Amersham-
Pharmacia Biotech, Austria). Antibodies to GFP (polyclonal and
monoclonal) were from Clontech (Germany).
2.3. Cell culture and transfection
Mouse melanoma cells (B16F1) from the American Type Culture
Collection were maintained in high glucose (4500 mg/l) Dulbecco’s
modi¢ed Eagle’s medium (Sigma-Aldrich, Austria) supplemented
with 10% foetal calf serum (FCS; PAA Laboratories, Austria) at
37‡ in the presence of 5% CO2. Cells were transfected at about 70%
con£uence overnight in the presence of serum, using 6 Wl Superfect
(Qiagen) and 1.5 Wg DNA for a 30 mm dish. They were plated onto
15 mm acid-washed glass coverslips coated with 25 Wg/ml laminin
(Sigma-Aldrich, Austria). For video microscopy, in air, B16F1 cells
were transferred to Ham’s F12 medium (Sigma-Aldrich, Austria) con-
taining 10% FCS.
2.4. Alumino£uoride treatment, phalloidin staining and £uorescence
microscopy
Transfected or untransfected B16F1 cells on laminin were subjected
to alumino£uoride treatment by adding 50 WM AlCl3 and 30 mM
NaF (¢nal concentration) to full growth medium for 5^40 min. For
¢xation, cells were washed shortly three times with phosphate-bu¡-
ered saline (PBS) (138 mM NaCl, 26 mM KCl, 84 mM Na2HPO4, 14
mM KH2PO4, pH 7.4), extracted with 0.3% Triton X-100 and 4%
paraformaldehyde (PFA; Merck, Germany) in PBS for 30 s. After
an additional three washing steps they were ¢xed with 4% PFA for 10
min. F-actin was visualised using Alexa 568 phalloidin according to
the manufacturer’s protocol (Molecular Probes, The Netherlands).
Fluorescent images were recorded on an Axioskop equipped with
an Axiocam using a 63U oil immersion lens and Axiovision 2.05
software (all Zeiss, Austria).
2.5. Video microscopy
Cells were mounted in an open heating chamber (Warner Instru-
ments, UK) at 37‡C on an inverted microscope (Axiovert S100TV;
Zeiss, Austria) equipped for epi£uorescence and phase contrast mi-
Fig. 1. Constructs of Scar used in this study (A) and their expres-
sion in B16F1 melanoma cells as determined by Western blotting
with a monoclonal GFP antibody (B,C). The full length Scar^GFP
(B) was only weakly expressed, and was therefore enriched by im-
munoprecipitation from cell extracts with a polyclonal GFP anti-
body, before immunoblotting. For the WA^GFP construct, total
cell extracts were used (C). Abbreviations: SHD; Scar homology
domain; B, basic region; pro-rich, proline-rich region; WA, WASP
homology and acidic domain [9].
Fig. 2. Fluorescence image of a B16F1 cell expressing Scar^GFP
that was ¢xed and labelled with Alexa 568 phalloidin. (No alumin-
ium £uoride treatment.) Lower panel shows boxed inset in upper
panel.
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croscopy, using a 100U/NA 1.4 plan apochromatic objective. Data
were acquired with a back-illuminated, cooled charged-coupled-device
(CCD) camera (Princeton Research Instruments, NJ, USA) driven by
IPLab software (Scanalytics, MA, USA) and with computer con-
trolled shutters (Optilas, Germany) in the transmitted and epi£uores-
cence light paths to minimise radiation damage to cells.
3. Results and discussion
The full length construct of Scar1 showed di¡erent levels of
expression in B16F1 mouse melanoma cells according to the
end to which GFP was tagged, the C-terminal tag giving low-
er expression. As in former studies [9], we found that over-
expression of Scar1 generally compromised cell spreading. We
therefore focused on weak expressers carrying the C-terminal
GFP tag, that could spread normally. As seen in Fig. 1, West-
ern blotting of immunoprecipitates of extracts from trans-
fected cells showed that the tagged full length construct mi-
grated at the expected molecular weight. When plated on
laminin, a small proportion of well spread cells could be
found that expressed detectable levels of GFP £uorescence,
following ¢xation. Counterstaining with phalloidin showed
that Scar1^GFP was localised to the tips of the actin network
of the lamellipodium (Fig. 2). Contrary to observations on
other cells [12] and consistent with the ¢ndings of Miki et
al. [8] we observed no localisation in focal adhesions. Motile
B16F1 melanoma cells characteristically show small surface
patches in phase contrast that move laterally and which either
pinch o¡ from the lamellipodium and move inwards, or form
spontaneously on the dorsal surface. These ‘ru¥ets’, which
were earlier described in 3T3 cells injected with constitutively
active Rac [22] also recruit Scar^GFP (see supplementary vid-
eos on ftp site (ftp://movies@server4.imolbio.ocean.ac.at,
user: movies, password: scar)).
For living B16F1 melanoma cells plated on laminin, the
proportion of cells with well developed lamellipodia is highly
variable and between 20 and 50%. We found that this pro-
portion could be dramatically and reproducibly increased, by
Fig. 3. Activation of protrusion of B16F1 cells by aluminium £uoride. Cells were ¢xed and then labelled with Alexa 568 phalloidin. A: Control
cells. B: Cells treated with aluminium £uoride for 20 min.
Fig. 4. B16F1 melanoma cell transfected with Scar^GFP, before (far left panel) and after treatment with aluminium £uoride for the times giv-
en. Note enhancement of GFP signal at the cell edge (£uorescence image) and the formation of a prominent lamellipodium (denser, peripheral
band in phase contrast) in aluminium £uoride.
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up to 80%, by the addition of aluminium £uoride to the me-
dium (Fig. 3). Under these conditions, cells developed wide
and smooth lamellipodia that were almost devoid of ¢lopodia.
As a phosphate analogue, aluminium £uoride binds with high
a⁄nity, but reversibly, to sites in proteins occupied by phos-
phate (reviewed in [23]) and therefore has many putative tar-
gets. The enhancement of motility and spreading was, how-
ever, Rac1-dependent, as it was markedly reduced in cells
expressing dominant-negative N17 Rac (data not shown).
We assume that B16F1 cells express Rac at high levels and
that Rac becomes activated during aluminium £uoride treat-
ment. However, other targets must also be involved, since the
activation of Rac alone, by injection of constitutively active
L61 Rac, produces a non-polarised phenotype ([22] and un-
published observations). In particular, aluminium £uoride sta-
bilises actin ¢laments [24] an e¡ect that could contribute to
the potentiation of protrusion.
Fig. 4 shows a cell transfected with Scar^GFP before and
after aluminium £uoride was added. The initially £uctuating
cell edge was transformed after 15 min treatment into a con-
tinuously protruding cell front with a clearly de¢ned lamelli-
podium in phase contrast. Concomitantly, the Scar^GFP sig-
nal at lamellipodium tips increased by up to 30%. This e¡ect
was typical for cells exhibiting low levels of GFP £uorescence,
whereas high expressors showed almost no response to the
compound. A second example, in Fig. 5, shows a cell for
which one region of the lamellipodium retracted during the
video sequence. In the same manner as observed for VASP^
GFP [17] Scar^GFP became delocalised from the cell edge
during retraction. Owing to the sensitivity of cells to high
levels of Scar expression, it was not readily possible to quan-
titate the levels of Scar intensity in relation to protrusion rate,
as previously achieved with VASP [17]. Thus, for cells that
were still competent to protrude lamellipodia, the signal of
Scar^GFP at lamellipodia tips was at the limit of the detection
level of the rear-illuminated CCD chip, typically 10^20 times
lower than that obtained with VASP^GFP. Nevertheless, of
the cells recorded (17 in total), all showed the same character-
istic localisation, associated with protrusion.
As indicated, ¢lopodia formation was suppressed by
aluminium £uoride treatment. Cells expressing very low levels
of Scar^GFP and that spontaneously formed lamellipodia and
¢lopodia were therefore screened to determine whether Scar
was also recruited to ¢lopodia. Fig. 6 shows a comparison of
lamellipodia and ¢lopodia in B16F1 cells transfected, respec-
tively, with GFP^VASP (Klemens Rottner, unpublished ob-
servations) and Scar^GFP. Whereas GFP^VASP was clearly
localised to ¢lopodia tips, the ¢lopodia in the Scar-transfected
cell, seen in phase contrast, were devoid of GFP label. This
result is consistent with the ¢nding of Miki et al. [8] that Scar1
lacking the verprolin homology part of the WA domain
blocks lamellipodia but not ¢lopodia protrusion when co-ex-
pressed, respectively, with constitutively active Rac or Cdc42.
The C-terminal, WA domain of Scar1 binds both G-actin
and the p21-Arc subunit of the Arp2/3 complex [9]. Expres-
sion of this domain in ¢broblasts and macrophages was found
to block lamellipodia formation, and in macrophages also
¢lopodia formation, e¡ects attributed to the disruption of
the normal Scar/WASP^Arp2/3 interaction [9]. Using alumi-
nium £uoride, we were able to induce lamellipodia in B16F1
cells expressing WA^GFP (Figs. 1 and 7). That the WA^GFP
construct was functionally active was shown in separate ex-
periments in which WA^GFP and the myc-tagged WA con-
struct used by Machesky and Insall [9] were transfected into
Fig. 5. B16F1 melanoma cell transfected with Scar^GFP and activated with aluminium £uoride 15 min before ¢rst frame of sequence (A).
Time between frames is 10 min. Upper panels: £uorescence images; lower panels: phase contrast. Note that the retraction of the lamellipodi-
um, initiated in C (arrows) and complete in D (see phase contrast) is associated in D with a delocalisation of Scar from the cell edge.
Fig. 6. Correlated phase contrast and £uorescence images of regions
of B16 cells that were transfected with either Scar^GFP or VASP^
GFP. (No aluminium £uoride treatment.) Filopodia tips recruit
VASP, but not Scar.
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PtK2 cells. After overnight incubation, cells transfected with
either construct showed a similar degree of stress ¢bre disas-
sembly, as compared to untransfected cells (data not shown).
As shown in Fig. 7, the WA domain was not recruited to the
lamellipodium in B16F1 cells, indicating that the N-terminal
region of Scar may be required for targeting it to sites des-
tined to nucleate actin ¢lament growth. Preliminary studies to
test this conclusion have been hampered so far, however, by
the spontaneous degradation of N-terminal Scar^GFP con-
structs in B16F1 cells.
Our present ¢ndings show that Scar is recruited speci¢cally
to sites of assembly of actin ¢laments for the formation of
lamellipodia. VASP and pro¢lin are recruited to the same
sites, but in addition to the tips of ¢lopodia, from which
Scar is excluded. Pathogens that use actin to move recruit
di¡erent combinations of molecular intermediates to e¡ect
actin polymerisation via the the Arp2/3 complex [14]. By anal-
ogy, we suppose that lamellipodia and ¢lopodia are induced
and controlled by alternative and more complex assemblies of
receptor, adaptor and regulatory molecules, recruited to the
membrane^actin interface. A future challenge will be to char-
acterise the molecular composition of these complexes and
their mode of control of actin ¢lament assembly. The local-
isation of molecules in living cells, as here, is going to be one
essential requirement to achieve this aim.
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